Detalles de la búsqueda
1.
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes.
Eur J Clin Invest
; 54(3): e14121, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37929812
2.
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
Diabetes Obes Metab
; 26(6): 2390-2400, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477183
3.
Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors.
Int J Mol Sci
; 25(11)2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38892122
4.
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.
Diabetologia
; 66(2): 354-366, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280617
5.
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.
Cardiovasc Diabetol
; 22(1): 349, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38115004
6.
Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis.
Diabetes Metab Res Rev
; 39(7): e3668, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37309298
7.
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events.
Diabetes Obes Metab
; 25(2): 444-453, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205446
8.
Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes.
Cardiovasc Diabetol
; 21(1): 57, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35473579
9.
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.
Cardiovasc Diabetol
; 21(1): 173, 2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057768
10.
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
Mol Biol Rep
; 49(2): 1623-1630, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846648
11.
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis
; 32(6): 1353-1360, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422359
12.
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis
; 32(2): 511-514, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893404
13.
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis
; 32(3): 529-536, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144855
14.
Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails.
Nutr Metab Cardiovasc Dis
; 32(2): 330-336, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893413
15.
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis
; 31(10): 2745-2755, 2021 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364771
16.
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
Diabetes Metab Res Rev
; 36(6): e3304, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32118347
17.
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.
Diabetes Obes Metab
; 22(11): 2089-2096, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32618383
18.
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Cardiovasc Diabetol
; 18(1): 20, 2019 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819210
19.
Sodium-glucose co-transporter inhibitors: Medications that mimic fasting for cardiovascular prevention.
Diabetes Obes Metab
; 21(10): 2211-2218, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209982
20.
The Interplay between Immune System and Microbiota in Diabetes.
Mediators Inflamm
; 2019: 9367404, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32082078